[Use of peptides in psychiatry and neurology (review)].
作者信息
Bulaev V M
出版信息
Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(8):1244-8.
PMID:3314286
Abstract
摘要
相似文献
1
[Use of peptides in psychiatry and neurology (review)].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(8):1244-8.
2
[The chronobiological approach--a way to enhance the efficacy of pharmacotherapy in neurology and psychiatry].
Eksp Klin Farmakol. 1992 Jul-Aug;55(4):67-9.
3
[Off-label use of drugs in psychiatry and neurology].[精神科和神经科药物的超说明书用药]
Fortschr Neurol Psychiatr. 2004 May;72(5):243-4. doi: 10.1055/s-2003-812452.
4
[Use of calcium inhibitors in neuropsychiatric pathology].[钙抑制剂在神经精神病理学中的应用]
Therapie. 1990 Mar-Apr;45(2):131-7.
5
[Use of fenibut in psychiatry and neurology and its place among other psychotropic drugs (review of the literature)].[芬乙脲在精神病学和神经病学中的应用及其在其他精神药物中的地位（文献综述）]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1989;89(4):142-51.
6
Cholinomimetic treatment of neuropsychiatric disorders: a review of recent developments.
Mt Sinai J Med. 1979 Sep-Oct;46(5):455-9.
7
[Features of the pharmacotherapy of nervous and mental diseases in gerontology].
Klin Med (Mosk). 1986 Sep;64(9):12-7.
8
[The pharmacological properties of calcium channel blockers and the outlook for their use in psychiatry and neurology].[钙通道阻滞剂的药理学特性及其在精神病学和神经病学中的应用前景]
Zh Nevrol Psikhiatr Im S S Korsakova. 1994;94(1):104-8.
9
Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology.选择性D-1多巴胺受体激动剂和拮抗剂在精神病学和神经病学中的治疗潜力。
Gen Pharmacol. 1988;19(1):55-60. doi: 10.1016/0306-3623(88)90005-5.
10
[Use of propranolol and other beta-adrenolytic drugs in the treatment of nervous system diseases].[普萘洛尔及其他β-肾上腺素能阻滞剂在神经系统疾病治疗中的应用]
Wiad Lek. 1984 Nov 15;37(22):1781-6.
引用本文的文献
1
Peptidergic modulation of learning a motoric food-procuring conditioned reflex skill.学习一种获取食物的运动性条件反射技能的肽能调节
Neurosci Behav Physiol. 1992 Sep-Oct;22(5):357-63. doi: 10.1007/BF01186626.
Zotero 插件